Skip to main content
TipRanks
Go Ultimate75% OFF

Gerrit Dispersyn Insider Profile

4 Followers

Gerrit Dispersyn, President & CEO, Director at Phio Pharmaceuticals, holds 212.33K shares in Phio Pharmaceuticals (Ticker: PHIO).

Gerrit Dispersyn's Trading History

PHIO
Phio Pharmaceuticals
Mar 03, 2022President & CEO, DirectorUninformative Sell7.34K$159.67K
PHIO
Insider Shares: 212.33K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 03, 2022Uninformative Sell$7.34K8,954$0.82―
Feb 16, 2022Uninformative Buy$0.00126,000$0.00―
Aug 17, 2021Informative Buy$9.78K6,000$1.63-56.20%
Mar 05, 2021Informative Buy$5.00K1,953$2.56-68.00%
Mar 03, 2021Informative Buy$7.58K2,500$3.03-68.60%

You May Also Like

Gerrit Dispersyn insider profile FAQ

What is the percentage of profitable transactions made by Gerrit Dispersyn?
The percentage of profitable transactions made by Gerrit Dispersyn is 0%.
What is the average return per transaction made by Gerrit Dispersyn?
The average return per transaction made by Gerrit Dispersyn is -58.80%.
What stocks does Gerrit Dispersyn hold?
Gerrit Dispersyn holds: PHIO stocks.
What was Gerrit Dispersyn’s latest transaction?
Gerrit Dispersyn’s latest transaction was an Uninformative Sell of $7.34K.
What was Gerrit Dispersyn's most profitable transaction?
Gerrit Dispersyn’s most profitable transaction was an Informative Buy of PHIO stock on August 19, 2020. The return on the trade was -35.40%.
What is Gerrit Dispersyn's role in Phio Pharmaceuticals?
Gerrit Dispersyn's role in Phio Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.